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Background: Exercise therapy is an important treatment option for people with 27 
intermittent claudication (IC). Appropriate reporting of exercise interventions in 28 
populations with IC within randomised controlled trials (RCTs) is important to 29 
ensure that research can be translated into clinical practice. Therefore, the 30 
purpose of our review is to evaluate the reporting of exercise interventions in 31 
RCTs of exercise therapy in patients with IC. 32 
Methods: A systematic search was performed to identify relevant trials in 33 
patients with IC published until May 2020. Studies including only participants 34 
with critical-limb ischemia or asymptomatic peripheral artery disease were 35 
excluded. Each trial was scored using the recently developed ‘Consensus on 36 
Exercise Reporting Template’ (CERT) which has a maximum obtainable score 37 
of 19.  38 
Results: Of 1489 unique records identified from the search, 73 trials were 39 
included reporting 107 exercise interventions. Overall, the average CERT score 40 
was 10/19. The exercise equipment used, the use of supervision and a 41 
description of whether the exercise prescription was tailored or generic were the 42 
most frequently reported intervention components. The motivational strategies 43 
used, intervention adherence, and intervention fidelity were the most under 44 
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reported CERT components. There was no trend indicating that CERT scores 45 
were higher in more recent publications.  46 
Conclusions: We have identified that important details about exercise 47 
interventions are frequently missing from the published literature. These missing 48 
data hinder replication of research findings and limit the translation of evidence 49 










Peripheral arterial disease (PAD) is characterised by atherosclerosis of the 56 
arteries supplying the lower limbs, resulting in a reduced blood supply. The 57 
prevalence of PAD is estimated to have increased by 23.5% between 2000 and 58 
2010(1) with current estimates at 237 million people affected globally(2). Around 59 
20-25% of individuals over 60 years old experience symptoms from PAD(3), 60 
most commonly intermittent claudication (IC). IC is a reproducible leg pain or 61 
discomfort that manifests during physical exertion, typically walking, and is 62 
relieved by rest. IC has deleterious effects on quality of life and is associated 63 
with an increased mortality risk(4).  64 
A first-line treatment for IC is exercise therapy; a prescription of regular 65 
supervised exercise to improve quality of life via improvements in walking 66 
performance. The efficacy of exercise therapy for improving walking 67 
performance is supported by Level 1A evidence(5). As such, supervised 68 
exercise training is recommended for the management of IC by the European 69 
Society for Vascular Surgery & European Society of Cardiology (6), the UK 70 
National Institute for Health and Care Excellence(7) and the American Heart 71 
Association(8).  72 
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Notwithstanding evidence supporting the efficacy of exercise therapy in clinical 73 
trials, its effectiveness (i.e. real-world treatment effect) is less clear. 74 
Shortcomings with service provision(9, 10), programme uptake and 75 
adherence(11) are amongst the known factors that have limited the 76 
effectiveness of simply recommending exercise therapy. Despite this, how it is 77 
implemented in practice is poorly understood, precluding the advancement of 78 
practical guidance. Current guidance is based on highly heterogenous literature 79 
in terms of the treatment context, healthcare professional training/discipline, 80 
population characteristics and exercise prescription - the frequency, intensity, 81 
time and type of exercise which together constitute the dose of exercise 82 
received(12). Whilst it is encouraging that in a pooled analysis exercise has a 83 
meaningful benefit in this population, there remains a challenge for distilling 84 
knowledge about how to optimally provide this key treatment.  85 
Very few published studies have evaluated the effectiveness of exercise 86 
programmes in routine care. Underlying this is the reality that exercise therapy 87 
is a complex intervention; multiple components within an exercise prescription 88 
interact to achieve an effective exercise dose which must be sustained for an 89 
adequate period to achieve the desired therapeutic effect. Exercise 90 
interventions therefore require detailed descriptions to enable efficacious 91 
research protocols to be faithfully implemented in practice and to inform robust 92 
evaluations of exercise services. 93 
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To understand and reliably reproduce the effects of an exercise protocol used in 94 
a trial, sufficient detail regarding how the intervention was conducted must be 95 
provided. Therefore, this review aimed to evaluate the quality of reporting of 96 
published exercise interventions used to treat IC in randomised controlled trials 97 
(RCTs). Collating the components of published exercise interventions also will 98 
allow us to clarify the inferences that can be made from available data about 99 
exercise programming and prescription for people with IC. This will enable us to 100 
identify future research priorities in this field. 101 
Methods 102 
This review was conducted in line with the Preferred Reporting Items for 103 
Systematic Review and Meta-Analysis (PRISMA) guidance(13). 104 
Search Strategy 105 
Four databases; CINAHL, Medline, EMBASE and Cochrane CENTRAL were 106 
searched from 1995 to May 2020. In addition, five existing systematic reviews 107 
and meta-analyses were manually searched to identify other trials eligible for 108 
inclusion(5, 14-17). Only studies published in the English language and relating 109 
to adults with IC (over 18 years of age) were included. Titles and abstracts were 110 
independently interrogated for inclusion by two reviewers (SB & SP) and 111 
disagreements resolved by discussion. The full text of any potentially eligible 112 
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article was then screened against the inclusion and exclusion criteria. Full 113 
search strategies can be found in Supplementary material 1. 114 
Eligible articles 115 
We included prospective RCTs where patients with IC (typical and atypical) 116 
were randomised to at least one arm that included a structured supervised or 117 
unsupervised exercise programme. We defined a structured exercise training 118 
programme was defined as one that stated the prescribed frequency, intensity 119 
and /or duration. No limits were placed on the type or duration of the exercise 120 
intervention. We elected to exclude studies that were published prior to 1995 as 121 
the majority of exercise programmes published after this date were designed 122 
using the recommendation of a specific meta-analysis(18). Studies including 123 
patients with critical-limb ischemia or asymptomatic PAD were also excluded. 124 
Outcomes 125 
To assess the quality of the reporting of the exercise intervention used in these 126 
trials the ‘Consensus on Exercise Reporting template’ (CERT) was used(19). 127 
The CERT was developed and endorsed by an international panel of experts to 128 
allow a standardised appraisal of published exercise rehabilitation interventions. 129 
It comprises a 16-item checklist that was designed to evaluate the 130 
completeness of reporting of exercise descriptions and spans the ‘who’, ‘what’, 131 
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‘when’, ‘where’ and ‘how’ of exercise interventions. We utilised the CERT 132 
‘Explanation and Elaboration Statement’ to inform scoring(19). Each item of the 133 
CERT was scored as a binary outcome (adequately reported vs inadequately 134 
reported, unclear or not reported at all) with a maximum possible score of 19.  135 
Data Extraction 136 
Five assessors (SI, SB, EC, SP, AH) independently reviewed and extracted 137 
data using a standardised, purpose-built database.  Where a study included 138 
more than one intervention arm which involved exercise, data were extracted 139 
for each arm and the individual intervention was evaluated rather than only the 140 
study. Extraction for each study was cross checked for accuracy and 141 
completeness by two reviewers (SI & AH). Data extraction included study 142 
characteristics, sample size, description of exercise prescription according to 143 
the ‘FITT principle’ (Frequency, Intensity, Time and Type of exercise performed) 144 
and information related to each CERT item(19). In addition, whilst the first 145 
CERT item considers whether a description of the exercise equipment is 146 
provided, we also recorded whether the make or model of equipment was 147 
reported, but this did not contribute to the overall CERT score. Where 148 
applicable, we consulted additional study sources (i.e. protocols and 149 
supplementary materials) to aid scoring. 150 
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Data Synthesis 151 
A narrative synthesis of the reporting of exercise interventions was performed. 152 
Intervention content was summarised by item according to the CERT checklist 153 
and FITT descriptors. To examine the change in intervention reporting quality 154 
over time, a Spearman correlation coefficient was calculated between the year 155 
of study publication and a study’s CERT score. Alpha was accepted as p<0.05. 156 
Results 157 
Database searches identified 1489 unique records. Of these, 73 trials, 158 
comprising 107 exercise interventions, met the(20) inclusion criteria and were 159 
ultimately included in this review (Figure 1)(21-87).  160 
CERT score 161 
A summary of the scores for each CERT item is provided in Figure 2. The mean 162 
CERT score was 10 ± 3 out of a possible 19. The CERT score for each 163 
intervention is displayed in Figure 3. Only 28% of interventions scored more 164 
than 11/19. There was no difference between the CERT scores in the 11 165 
studies published after the CERT guidance was released and those that pre-166 
dated the CERT (11.3 ± 3.3 vs 9.9 ± 3.2; p = 0.127). There was no relationship 167 
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between year of publication and CERT score (ρ=0.14, p=0.14, Supplemental 168 
Figure 1). 169 
Question 1: detailed description of the type of exercise equipment. 170 
The mode of exercise performed was typically described with an indication of 171 
the type of equipment used (if any) such as a treadmill or Nordic walking poles. 172 
However, only 36% of studies that described the use of equipment gave specific 173 
details of the make or model used. 174 
Question 2: detailed description of the qualifications, expertise 175 
and/or training. 176 
Less than half (47%) of the included interventions provided a description of the 177 
qualifications, profession and/or training of those delivering the exercise 178 
intervention. A variety of professions were described including physiotherapists 179 
(most common), vascular nurses, research nurses, exercise physiologists, 180 
exercise instructors, rehabilitation assistants, vascular technologists, and 181 
research assistants. 182 
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Question 3: describe whether exercises are performed individually 183 
or in a group. 184 
Information regarding whether interventions were delivered in a group or 185 
individually was limited, with only 34% of interventions providing this specific 186 
information. 187 
Question 4: describe whether exercises are supervised or 188 
unsupervised; how they are delivered. 189 
The vast majority (94%) of interventions reported the level of supervision 190 
provided in each intervention. 191 
Question 5: detailed description of how adherence to exercise is 192 
measured and reported. 193 
Few interventions (33%) provided a description of how they defined adherence 194 
to the intervention. If adherence was measured it was typically via self-reported 195 
activity logs or records of attendance to supervised sessions. 196 
Question 6: detailed description of motivation strategies. 197 
Very few interventions (15%) described the use of behavioural or motivational 198 
strategies to support adherence to the intervention. Examples include providing 199 
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information about the benefits of exercise via written materials or having weekly 200 
telephone contact with a nurse or exercise professional who provided support 201 
adhere to the intervention.  202 
Question 7a: detailed description of the decision rule(s) for 203 
determining exercise progression; Question 7b: detailed description 204 
of how the exercise programme was progressed. 205 
A decision rule determining how the dose of exercise would be progressed 206 
based on an individuals’ performance was provided in less than half of the 207 
interventions (47%); for example, increasing the speed or elevation of a 208 
treadmill when a participant walked for 8 minutes without reaching moderate 209 
pain. Occasionally, a general rule for exercise dose progression was employed 210 
irrespective of individual performance, such as increasing the duration of 211 
walking in a session by 5 minutes every two weeks. Accordingly, descriptions of 212 
how exercise was progressed were better reported (69%). Progression was 213 
typically made by increasing the exercise intensity (e.g. the speed or gradient of 214 
treadmill walking) or total duration.  215 
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Question 8: detailed description of each exercise to enable 216 
replication. 217 
An adequate description of the exercises that made up the intervention that 218 
would enable replication was provided in most instances (87%). However, it 219 
was noted that many instructions were imprecise and could be interpreted and 220 
implemented in various ways. For example, where multiple exercises were used 221 
within an intervention it was often unclear how vigorous an effort one should 222 
make for different exercises, whether the order of exercises was fixed or 223 
variable, or whether rest periods were used within or between exercise bouts. 224 
Question 9: detailed description of any home programme 225 
component. 226 
Half of the interventions described a home-based component such as 227 
completing the entire programme at home or supplementing centre-based 228 




Question 10: describe whether there are any non-exercise 231 
components. 232 
Additional intervention components such as the provision of written or verbal 233 
advice regarding diet, weight loss, physical activity or smoking cessation were 234 
infrequently reported (28%). Other examples include specification of the 235 
standard of medical care in study participants such as the provision of 236 
antiplatelet and lipid-lowering therapies. 237 
Question 11: describe the type and number of adverse events that 238 
occurred during exercise. 239 
Reporting of adverse events was low (37%). Most studies that commented on 240 
adverse events stated that none occurred. In some instances, only 241 
unanticipated or serious adverse events were reported. Of the studies that 242 
reported adverse events, most did not specify whether an adverse event was 243 
related to the intervention - only one related event was reported 244 
(musculoskeletal injury). Other instances of adverse events were not 245 
adequately described to identify whether they were caused by the intervention. 246 
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Question 12: describe the setting in which the exercises are 247 
performed. 248 
Less than half of the interventions (47%) described the environment (gym, 249 
laboratory, outdoors, etc.) where exercise was performed.  250 
Questions 13: detailed description of the exercise intervention; 14a: 251 
describe whether the exercises are generic (one-size-fits-all) or 252 
tailored; 14b: detailed description of how exercises are tailored to 253 
the individual. 254 
Most studies provided a detailed description of the exercise intervention (88%) 255 
and provided information as to whether the exercise prescription was generic or 256 
individually tailored (95%). Only 60% of interventions provided a detailed 257 
description of how exercise was individually tailored. 258 
Question 15: describe the decision rule for determining the starting 259 
level. 260 
Only 47% of interventions described a decision rule that was used to determine 261 
the initial exercise dose prescribed to a participant: such as walking at 75% of 262 
the workload achieved on a treadmill test. 263 
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Question 16a: describe how adherence or fidelity is assessed/ 264 
measured; 16b: describe the extent to which the intervention was 265 
delivered as planned. 266 
It was rarely reported (17%) that adherence to the intervention was assessed. 267 
In most instances where fidelity was considered, the limited definition of 268 
attendance to training sessions was used. This assumes that the delivery of 269 
exercise during sessions is perfect or very consistent. Only 32% of interventions 270 
reported that they were delivered as planned – either in writing or via reported 271 
data. 272 
FITT descriptors 273 
Frequency 274 
The most common exercise frequency was 3 times per week (49/107), followed 275 
by daily exercise (29/107), two sessions per week (23/107), one session per 276 
week (3/107) and four, five or six sessions per week (1/107).  Fourteen 277 
interventions used complex prescriptions such as: 2-3 sessions per week, at 278 
least 3 sessions per week, 3 sessions per day, or had a variable frequency over 279 




Ten different categorisations of prescribing exercise intensity were employed. 282 
The most common prescription was a description of claudication pain intensity 283 
(28/107). The intensities ranged from the onset of claudication pain to maximal 284 
pain. However, the terms used to describe these intensities varied considerably. 285 
Terms such as “near pain threshold”, “till claudication was noted”, “moderately 286 
severe pain”, “submaximal pain”, “intense pain”, “near max pain” and 287 
“unbearable pain” were used. Two different scales were used to prescribe 288 
exercise by the intensity of claudication pain experienced: the ACSM scale 289 
which ranges from 1-4 (11/107) and the claudication pain scale (14/107) which 290 
ranges from 1-5. Treadmill tests were used to individually prescribe a treadmill-291 
specific workload in 16/107 interventions. Six interventions prescribed 292 
ergometer workloads (cycle or arm) from an ergometer test. Ten interventions 293 
prescribed intensity based on rating of perceived exertion and two based on an 294 
individual’s heart rate. Seven interventions prescribed resistance exercise via 295 
fixed loads, fixed repetition numbers, isokinetic dynamometer-based loads or as 296 
a percentage of one repetition maximum. Intensity prescriptions were not clearly 297 
specified in 11 interventions with some based on walking a “maximum distance” 298 
or walking “to tolerance” if reporting an intensity prescription at all. 299 
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Time  300 
The duration of exercise sessions was reported in almost all interventions 301 
(102/107) with some interventions prescribing completion of a volume of 302 
exercise without an indication of duration. Most interventions prescribed were 303 
for a duration of 30-59 minutes (63/107) or ⩾ 60 minutes (21/107).  304 
Type 305 
Treadmill walking was the most common modality of exercise prescribed 306 
(53/107), followed by outdoor/overground walking (19/107), circuit training 307 
(8/107), resistance training (6/107), Nordic-pole walking (6/107), cycling (5/107) 308 
or arm ergometry (3/107). Three interventions did not report the type of exercise 309 
prescribed. 310 
Discussion  311 
The aim of this study was to evaluate the quality and completeness of reporting 312 
in published exercise interventions for patients with IC which has been defined 313 
by the CERT(19) and exercise dose according to the FITT principles. Overall, 314 
we identified 107 exercise interventions from 73 studies that adopted a variety 315 
of exercise modalities. Our main finding was that, in general, the quality of 316 
reporting of exercise interventions for patients with IC was poor.  317 
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Only 8 out of 19 of the CERT criteria were reported in most interventions. The 318 
components that were well reported included the type of equipment used, 319 
supervision, a description of the exercises provided, a description of the 320 
exercise intervention and whether it was a tailored or generic programme. The 321 
highest CERT score was 18/19 which was attained by one intervention which 322 
only omitted to describe how fidelity was assessed(88). Furthermore, there was 323 
no trend to suggest intervention reporting quality had improved over the last 25 324 
years. 325 
The least reported aspect was the use of motivational strategies (question 6), 326 
described in only 15% of interventions. Whether this result is artificially low due 327 
to a reporting bias is unclear. Investigators may not realise the importance of 328 
reporting such strategies, even when they are used. Engaging patients with IC 329 
in exercise interventions is challenging, and poor uptake and adherence rates 330 
have been noted(11), often because patients desire a “quick-fix” for their 331 
symptoms(89). Plausibly, the application of known facilitators to exercise 332 
behaviour such as goal setting, accessing support systems(90) or many other 333 
potentially effective behaviour change techniques(91) may improve adherence 334 
to exercise interventions. That the use of behavioural support strategies is 335 
seldom reported limits our understanding of how to promote adherence to 336 
exercise in clinical trials and routine care. This problem is compounded by poor 337 
reporting of exercise adherence. 338 
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The fidelity of, or adherence to, an exercise intervention was reported for only 339 
17% of interventions (question 16a). These results are congruent with those of 340 
others using different reporting frameworks(92). Intervention fidelity is integral 341 
for determining the internal and external validity of intervention based trials(93, 342 
94), is endorsed by the CONSORT recommendations(95) and should be 343 
reported in all RCTs. This presents a significant potential confounder of pooled 344 
analyses of exercise interventions. Different treatment effects might be 345 
expected for interventions with 40% versus 80% adherence, but at present we 346 
are largely unable to characterise this effect. Where intervention adherence was 347 
described, it was predominantly limited to a description of attendance to 348 
exercise sessions. More comprehensive reporting of adherence to an 349 
intervention should include a description of the exercise intensity achieved 350 
during training and total duration of exercise performed at the prescribed 351 
intensity. 352 
Merely recording attendance is not a sufficient measure of intervention fidelity 353 
as this assumes that the exercise being performed is of an adequate intensity, 354 
type and duration (i.e. dosage) to elicit a benefit. Inadequate measurement and 355 
reporting of these components risks efficacious interventions being depicted as 356 
ineffective solely because of poor implementation. This could limit the support 357 
for this beneficial treatment and contribute to research waste. Such reporting 358 
issues have been identified for exercise interventions in hypertension(96), 359 
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breast cancer(97) and cardiac rehabilitation(98). Though exercise intensity was 360 
frequently reported (89% of interventions), ten different methods of prescription 361 
were used. There is limited consensus on what exercise intensity should be 362 
prescribed; with professional societies recommending walking to mild to 363 
moderate(99), moderate(3), near-maximal(100) and maximal pain(7). This 364 
heterogeneity, along with poor reporting of adherence, poses a major challenge 365 
for between study comparison of exercise interventions. There is a clear need 366 
for standardisation of the prescription and reporting of exercise intensity in this 367 
population. 368 
The other principles of exercise prescription include frequency, time and 369 
type(101). Clear reporting of these components is vital to allow replication of 370 
interventions and translate research knowledge into clinical guidelines for 371 
exercise. Of the 107 interventions included in this review all of them adequately 372 
reported the frequency of exercise. Forty-nine prescribed a frequency of three 373 
times per week in line with most current guidance(12). Time was reported in 374 
102/107 interventions (95%) and was predominantly 30-59 minutes in duration. 375 
Only 3/107 interventions did not describe the type of exercise prescribed. Our 376 
results suggest that these components are well reported in the IC literature, 377 
though they may not conform to the available clinical guidelines.  378 
Finally, the inclusion of non-exercise components was another poorly reported 379 
aspect of exercise interventions. These components may include dietary advice, 380 
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counselling, or patient education with regards to medication adherence or 381 
smoking cessation. Only 28% of interventions provided any details of these 382 
components, which may plausibly influence treatment outcomes. Again, it is 383 
unclear whether these components are underreported or simply absent from 384 
most interventions.  385 
Evidently, there is a need to improve reporting quality in this field; at present 386 
there are few tools available to achieve this. The CONSORT checklist is one 387 
such tool that has improved the reporting of aspects of RCTs(102) though more 388 
detailed definitions of intervention adherence may be required for complex 389 
interventions. Of the 16 (22%) studies that referred to the CONSORT reporting 390 
guidance in their manuscripts, only 4 attempted to adhere to this guidance 391 
(beyond the inclusion of a CONSORT diagram). No study included in this 392 
review made reference to the use of the CERT checklist or the TiDieR checklist. 393 
A prudent recommendation would be to require study authors to submit a 394 
research checklist as a supplementary material to improve the quality of 395 
reporting of exercise interventions in IC populations. The CERT is a 396 
comprehensive tool that specifies many important aspects of exercise 397 
interventions that should be reported, however at present it lacks IC specific 398 
criteria pertaining to the exercise prescription. As such, we recommend that a 399 
novel checklist should be developed and trialled to examine the effect of an IC 400 




By design, this review has only been able to describe the quality of reporting in 403 
the IC literature. It has not been able to investigate reasons for the observed 404 
shortcomings in reporting. Some details may be omitted due to word limits or a 405 
perceived lack of importance. Whether requiring greater detail in the reporting of 406 
exercise interventions in this population will increase the publication of trial 407 
protocols or cause the omission of other important information in manuscripts is 408 
unknown. 409 
Conclusion 410 
The reporting of exercise interventions in populations with IC is poor. In 411 
particular, the reporting of adherence to interventions, strategies to motivate 412 
individuals to exercise and non-exercise components of the interventions were 413 
rarely reported. Additionally, many different descriptions of exercise intensity 414 
were used which will hinder between study comparison. As such, 415 
standardisation of the prescription and reporting of exercise intensity in studies 416 
including patients with IC is essential. A concerted effort is needed on the part 417 
of researchers, reviewers, and journal editors to improve the quality of reporting 418 
of key aspects of exercise interventions to facilitate the advancement of 419 





None to report. 423 
Author contributions  424 
Conception and design, SI, SP, STB, EC and AEH; data extraction SI, SP, STB, 425 
EC and AEH; analysis and interpretation of data, SI and AEH; draft of article, SI 426 
and AEH; revision and editing work critically for important intellectual content, 427 
SI, SP, STB, EC and AEH. 428 
Declaration of interests 429 
The authors declare that there are no conflicts of interest.  430 
Funding support 431 
This study was conducted without funding. 432 
References  433 
1. Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott 434 
MM, et al. Comparison of global estimates of prevalence and risk factors for 435 
26 
 
peripheral artery disease in 2000 and 2010: a systematic review and analysis. 436 
The Lancet. 2013;382(9901):1329-40. 437 
2. Song P, Rudan D, Zhu Y, Fowkes FJ, Rahimi K, Fowkes FGR, et al. 438 
Global, regional, and national prevalence and risk factors for peripheral artery 439 
disease in 2015: an updated systematic review and analysis. The Lancet Global 440 
Health. 2019;7(8):e1020-e30. 441 
3. Norgen L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F. TASC II: 442 
Trans-Atlantic Inter-Society Consensus for the Management of Peripheral 443 
Arterial Disease on behalf of the TASC II Working Group. Eur J Vasc Endovasc 444 
Surg. 2007;33. 445 
4. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, 446 
Goodman D. The prevalence of peripheral arterial disease in a defined 447 
population. Circulation. 1985;71(3):510-5. 448 
5. Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent 449 
claudication. Cochrane Database of Systematic Reviews. 2017(12). 450 
6. Aboyans V, Ricco J-B, Bartelink M-LE, Björck M, Brodmann M, Cohnert 451 
T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral 452 
Arterial Diseases, in collaboration with the European Society for Vascular 453 
Surgery (ESVS) Document covering atherosclerotic disease of extracranial 454 
carotid and vertebral, mesenteric, renal, upper and lower extremity arteries 455 
Endorsed by: the European Stroke Organization (ESO) The Task Force for the 456 
Diagnosis and Treatment of Peripheral Arterial Diseases of the European 457 
Society of Cardiology (ESC) and of the European Society for Vascular Surgery 458 
(ESVS). European heart journal. 2018;39(9):763-816. 459 
7. National Institute for Health and Care Excellence. CG147.1.5  460 
Management of intermittent claudication. London: NICE; 2018. 461 
8. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, 462 
Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients 463 
with lower extremity peripheral artery disease: a report of the American College 464 
of Cardiology/American Heart Association Task Force on Clinical Practice 465 
Guidelines. Journal of the American College of Cardiology. 2017;69(11):e71-466 
e126. 467 
9. Makris G, Lattimer C, Lavida A, Geroulakos G. Availability of supervised 468 
exercise programs and the role of structured home-based exercise in peripheral 469 




10. Harwood AE, Pymer  S, Ibeggazene S, Ingle L, Caldow E, Birkett, et al. 472 
Provision of exercise services in patients with peripheral artery disease in the 473 
United Kingdom. Vascular. 2021;Online first. 474 
11. Harwood A-E, Smith GE, Cayton T, Broadbent E, Chetter IC. A 475 
systematic review of the uptake and adherence rates to supervised exercise 476 
programs in patients with intermittent claudication. Annals of vascular surgery. 477 
2016;34:280-9. 478 
12. Harwood AE, Pymer S, Ingle L, Doherty P, Chetter IC, Parmenter B, et 479 
al. Exercise training for intermittent claudication: a narrative review and 480 
summary of guidelines for practitioners. BMJ Open Sport & Exercise Medicine. 481 
2020;6(1):e000897. 482 
13. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting 483 
items for systematic reviews and meta-analyses: the PRISMA statement. PLoS 484 
med. 2009;6(7):e1000097. 485 
14. Hageman D, Fokkenrood HJ, Gommans LN, van den Houten MM, Teijink 486 
JA. Supervised exercise therapy versus home‐based exercise therapy versus 487 
walking advice for intermittent claudication. Cochrane Database of Systematic 488 
Reviews. 2018(4). 489 
15. Parmenter BJ, Raymond J, Dinnen P, Singh MAF. A systematic review of 490 
randomized controlled trials: walking versus alternative exercise prescription as 491 
treatment for intermittent claudication. Atherosclerosis. 2011;218(1):1-12. 492 
16. Fakhry F, van de Luijtgaarden KM, Bax L, den Hoed PT, Hunink MM, 493 
Rouwet EV, et al. Supervised walking therapy in patients with intermittent 494 
claudication. Journal of vascular surgery. 2012;56(4):1132-42. 495 
17. Vemulapalli S, Dolor RJ, Hasselblad V, Schmit K, Banks A, Heidenfelder 496 
B, et al. Supervised vs unsupervised exercise for intermittent claudication: a 497 
systematic review and meta-analysis. American Heart Journal. 498 
2015;169(6):924-37. e3. 499 
18. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the 500 
treatment of claudication pain: a meta-analysis. Jama. 1995;274(12):975-80. 501 
19. Slade SC, Dionne CE, Underwood M, Buchbinder R. Consensus on 502 
Exercise Reporting Template (CERT): explanation and elaboration statement. 503 
British journal of sports medicine. 2016;50(23):1428-37. 504 
28 
 
20. Crowther RG. Effects of a long term exercise program on lower limb 505 
mobility in peripheral arterial disease patients: James Cook University; 2008. 506 
21. Allen JD, Stabler T, Kenjale A, Ham KL, Robbins JL, Duscha BD, et al. 507 
Plasma nitrite flux predicts exercise performance in peripheral arterial disease 508 
after 3 months of exercise training. Free Radical Biology and Medicine. 509 
2010;49(6):1138-44. 510 
22. Babber A, Ravikumar R, Onida S, Lane TRA, Davies AH. Effect of 511 
footplate neuromuscular electrical stimulation on functional and quality-of-life 512 
parameters in patients with peripheral artery disease: pilot, and subsequent 513 
randomized clinical trial. British journal of surgery. 2020. 514 
23. Baker WB, Li Z, Schenkel SS, Chandra M, Busch DR, Englund EK, et al. 515 
Effects of exercise training on calf muscle oxygen extraction and blood flow in 516 
patients with peripheral artery disease. Journal of Applied Physiology. 517 
2017;123(6):1599-609. 518 
24. Brenner IK, Brown CA, Hains SJ, Tranmer J, Zelt DT, Brown PM. Low-519 
intensity exercise training increases heart rate variability in patients with 520 
peripheral artery disease. Biological research for nursing. 2020;22(1):24-33. 521 
25. Bronas UG, Treat-Jacobson D, Leon AS. Comparison of the effect of 522 
upper body-ergometry aerobic training vs treadmill training on central 523 
cardiorespiratory improvement and walking distance in patients with 524 
claudication. Journal of vascular surgery. 2011;53(6):1557-64. 525 
26. Cheetham D, Burgess L, Ellis M, Williams A, Greenhalgh R, Davies A. 526 
Does supervised exercise offer adjuvant benefit over exercise advice alone for 527 
the treatment of intermittent claudication? A randomised trial. European Journal 528 
of Vascular and Endovascular Surgery. 2004;27(1):17-23. 529 
27. Bulińska K, Kropielnicka K, Jasiński T, Wojcieszczyk-Latos J, Pilch U, 530 
Dąbrowska G, et al. Nordic pole walking improves walking capacity in patients 531 
with intermittent claudication: a randomized controlled trial. Disability and 532 
rehabilitation. 2016;38(13):1318-24. 533 
28. Chehuen M, Cucato GG, Carvalho CRF, Ritti-Dias RM, Wolosker N, 534 
Leicht AS, et al. Walking training at the heart rate of pain threshold improves 535 
cardiovascular function and autonomic regulation in intermittent claudication: a 536 




29. Christman SK. Intervention to slow progression of peripheral arterial 539 
disease. 2003. 540 
30. Collins EG, Langbein WE, Orebaugh C, Bammert C, Hanson K, Reda D, 541 
et al. PoleStriding exercise and vitamin E for management of peripheral 542 
vascular disease. Medicine & Science in Sports & Exercise. 2003;35(3):384-93. 543 
31. Collins TC, Lunos S, Carlson T, Henderson K, Lightbourne M, Nelson B, 544 
et al. Effects of a home-based walking intervention on mobility and quality of life 545 
in people with diabetes and peripheral arterial disease: a randomized controlled 546 
trial. Diabetes care. 2011;34(10):2174-9. 547 
32. Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J. 548 
Effects of a 6-month exercise program pilot study on walking economy, peak 549 
physiological characteristics, and walking performance in patients with 550 
peripheral arterial disease. Vascular health and risk management. 2012;8:225. 551 
33. Cucato GG, Chehuen MdR, Costa LAR, Ritti-Dias RM, Wolosker N, 552 
Saxton JM, et al. Exercise prescription using the heart of claudication pain 553 
onset in patients with intermittent claudication. Clinics. 2013;68(7):974-8. 554 
34. Delaney C, Miller M, Chataway T, Spark J. A randomised controlled trial 555 
of supervised exercise regimens and their impact on walking performance, 556 
skeletal muscle mass and calpain activity in patients with intermittent 557 
claudication. European Journal of Vascular and Endovascular Surgery. 558 
2014;47(3):304-10. 559 
35. Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann 560 
WH, et al. Endovascular revascularization and supervised exercise for 561 
peripheral artery disease and intermittent claudication: a randomized clinical 562 
trial. jama. 2015;314(18):1936-44. 563 
36. Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn 564 
WR, et al. Exercise rehabilitation improves functional outcomes and peripheral 565 
circulation in patients with intermittent claudication: a randomized controlled 566 
trial. Journal of the American Geriatrics Society. 2001;49(6):755-62. 567 
37. Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term 568 
exercise rehabilitation on claudication distances in patients with peripheral 569 
arterial disease: a randomized controlled trial. Journal of Cardiopulmonary 570 
Rehabilitation and Prevention. 2002;22(3):192-8. 571 
30 
 
38. Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of 572 
exercise intensity on the response to exercise rehabilitation in patients with 573 
intermittent claudication. Journal of vascular surgery. 2005;42(4):702-9. 574 
39. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy 575 
of quantified home-based exercise and supervised exercise in patients with 576 
intermittent claudication: a randomized controlled trial. Circulation. 577 
2011;123(5):491-8. 578 
40. Gardner AW, Montgomery PS, Parker DE. Optimal exercise program 579 
length for patients with claudication. Journal of vascular surgery. 580 
2012;55(5):1346-54. 581 
41. Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step‐monitored 582 
home exercise improves ambulation, vascular function, and inflammation in 583 
symptomatic patients with peripheral artery disease: a randomized controlled 584 
trial. Journal of the American Heart Association. 2014;3(5):e001107. 585 
42. Greenhalgh R. The adjuvant benefit of angioplasty in patients with mild-586 
to-moderate intermittent claudication (MIMIC) managed by supervised exercise, 587 
smoking cessation advice and best medical therapy: results from two 588 
randomised trials for occlusive femoropopliteal and aortoiliac occlusive arterial 589 
disease. European Journal of Vascular & Endovascular Surgery. 2008. 590 
43. Hageman D, Fokkenrood HJ, van Deursen BA, Gommans LN, Cancrinus 591 
E, Scheltinga MR, et al. Randomized controlled trial of vacuum therapy for 592 
intermittent claudication. Journal of vascular surgery. 2020;71(5):1692-701. e1. 593 
44. Hobbs SD, Marshall T, Fegan C, Adam DJ, Bradbury AW. The 594 
constitutive procoagulant and hypofibrinolytic state in patients with intermittent 595 
claudication due to infrainguinal disease significantly improves with 596 
percutaneous transluminal balloon angioplasty. Journal of vascular surgery. 597 
2006;43(1):40-6. 598 
45. Hobbs SD, Marshall T, Fegan C, Adam DJ, Bradbury AW. The effect of 599 
supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent 600 
claudication: a randomized controlled trial. Journal of vascular surgery. 601 
2007;45(1):65-70. 602 
46. Sandercock GR, Hodges LD, Das SK, Brodie DA. The impact of short 603 
term supervised and home-based walking programmes on heart rate variability 604 
in patients with peripheral arterial disease. Journal of sports science & 605 
medicine. 2007;6(4):471. 606 
31 
 
47. Jones PP, Skinner JS, Smith LK, John FM, Bryant CX. Functional 607 
improvements following StairMaster vs. treadmill exercise training for patients 608 
with intermittent claudication. Journal of Cardiopulmonary Rehabilitation and 609 
Prevention. 1996;16(1):47-55. 610 
48. Kakkos S, Geroulakos G, Nicolaides A. Improvement of the walking 611 
ability in intermittent claudication due to superficial femoral artery occlusion with 612 
supervised exercise and pneumatic foot and calf compression: a randomised 613 
controlled trial. European journal of vascular and endovascular surgery. 614 
2005;30(2):164-75. 615 
49. Kropielnicka K, Dziubek W, Bulińska K, Stefańska M, Wojcieszczyk-616 
Latos J, Jasiński R, et al. Influence of the physical training on muscle function 617 
and walking distance in symptomatic peripheral arterial disease in elderly. 618 
BioMed research international. 2018;2018. 619 
50. Lamberti N, Malagoni AM, Ficarra V, Basaglia N, Manfredini R, Zamboni 620 
P, et al. Structured home-based exercise versus invasive treatment: A mission 621 
impossible? A pilot randomized study in elderly patients with intermittent 622 
claudication. Angiology. 2016;67(8):772-80. 623 
51. Langbein WE, Collins EG, Orebaugh C, Maloney C, Williams KJ, Littooy 624 
FN, et al. Increasing exercise tolerance of persons limited by claudication pain 625 
using polestriding. Journal of vascular surgery. 2002;35(5):887-93. 626 
52. Leicht A, Crowther R, Muller R, Golledge J. The effects of including 627 
quality of life responses in models to predict walking performance of patients 628 
with intermittent claudication. European Journal of Vascular and Endovascular 629 
Surgery. 2011;41(4):511-7. 630 
53. Maejima Y, Yasu T, Ueba H, Kobayashi N, Hashimoto S, Kubo N, et al. 631 
Exercise After Heparin Administration New Therapeutic Program for Patients 632 
With Non-Option Arteriosclerosis Obliterans. Circulation Journal. 633 
2005;69(9):1099-104. 634 
54. Mays RJ, Hiatt WR, Casserly IP, Rogers RK, Main DS, Kohrt WM, et al. 635 
Community-based walking exercise for peripheral artery disease: An 636 
exploratory pilot study. Vascular Medicine. 2015;20(4):339-47. 637 
55. Mazari F, Gulati S, Rahman M, Lee H, Mehta T, McCollum P, et al. Early 638 
outcomes from a randomized, controlled trial of supervised exercise, 639 
angioplasty, and combined therapy in intermittent claudication. Annals of 640 
vascular surgery. 2010;24(1):69-79. 641 
32 
 
56. McGuigan MR, Bronks R, Newton RU, Sharman MJ, Graham JC, Cody 642 
DV, et al. Resistance training in patients with peripheral arterial disease: effects 643 
on myosin isoforms, fiber type distribution, and capillary supply to skeletal 644 
muscle. The Journals of Gerontology Series A: Biological Sciences and Medical 645 
Sciences. 2001;56(7):B302-B10. 646 
57. Mika P, Spodaryk K, Cencora A, Mika A. Red blood cell deformability in 647 
patients with claudication after pain-free treadmill training. Clinical Journal of 648 
Sport Medicine. 2006;16(4):335-40. 649 
58. Mika P, Wilk B, Mika A, Marchewka A, Niżankowski R. The effect of pain-650 
free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with 651 
claudication. European Journal of Cardiovascular Prevention & Rehabilitation. 652 
2011;18(5):754-60. 653 
59. Mika P, Konik A, Januszek R, Petriczek T, Mika A, Nowobilski R, et al. 654 
Comparison of two treadmill training programs on walking ability and endothelial 655 
function in intermittent claudication. International journal of cardiology. 656 
2013;168(2):838-42. 657 
60. Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, 658 
Reynolds MR, et al. Supervised exercise, stent revascularization, or medical 659 
therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER 660 
study. Journal of the American College of Cardiology. 2015;65(10):999-1009. 661 
61. Nicolaï SP, Teijink JA, Prins MH. Multicenter randomized clinical trial of 662 
supervised exercise therapy with or without feedback versus walking advice for 663 
intermittent claudication. Journal of Vascular Surgery. 2010;52(2):348-55. 664 
62. Nordanstig J, Taft C, Hensäter M, Perlander A, Österberg K, Jivegård L. 665 
Improved quality of life after 1 year with an invasive versus a noninvasive 666 
treatment strategy in claudicants: one-year results of the Invasive 667 
Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation. 668 
2014;130(12):939-47. 669 
63. Normahani P, Kwasnicki R, Bicknell C, Allen L, Jenkins MP, Gibbs R, et 670 
al. Wearable sensor technology efficacy in peripheral vascular disease 671 
(wSTEP): a randomized controlled trial. Annals of surgery. 2018;268(6):1113-8. 672 
64. Novaković M, Krevel B, Rajkovič U, Cuderman TV, Trontelj KJ, Fras Z, et 673 
al. Moderate-pain versus pain-free exercise, walking capacity, and 674 
cardiovascular health in patients with peripheral artery disease. Journal of 675 
vascular surgery. 2019;70(1):148-56. 676 
33 
 
65. Parmenter BJ, Raymond J, Dinnen P, Lusby RJ, Fiatarone Singh MA. 677 
High‐intensity progressive resistance training improves flat‐ground walking in 678 
older adults with symptomatic peripheral arterial disease. Journal of the 679 
American Geriatrics Society. 2013;61(11):1964-70. 680 
66. Parr BM, Noakes T, Derman E. Peripheral arterial disease and 681 
intermittent claudication: efficacy of short-term upper body strength training, 682 
dynamic exercise training, and advice to exercise at home. South African 683 
Medical Journal. 2009;99(11). 684 
67. Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M. Value 685 
of a supervised exercise program for the therapy of arterial claudication. Journal 686 
of Vascular Surgery. 1997;25(2):312-9. 687 
68. Ramaswami G, D’Ayala M, Hollier LH, Deutsch R, McElhinney AJ. Rapid 688 
foot and calf compression increases walking distance in patients with 689 
intermittent claudication: results of a randomized study. Journal of vascular 690 
surgery. 2005;41(5):794-801. 691 
69. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. 692 
Hospital vs home-based exercise rehabilitation for patients with peripheral 693 
arterial occlusive disease. Angiology. 1997;48(4):291-300. 694 
70. Sanderson B, Askew C, Stewart I, Walker P, Gibbs H, Green S. Short-695 
term effects of cycle and treadmill training on exercise tolerance in peripheral 696 
arterial disease. Journal of vascular surgery. 2006;44(1):119-27. 697 
71. Schlager O, Giurgea A, Schuhfried O, Seidinger D, Hammer A, Gröger 698 
M, et al. Exercise training increases endothelial progenitor cells and decreases 699 
asymmetric dimethylarginine in peripheral arterial disease: a randomized 700 
controlled trial. Atherosclerosis. 2011;217(1):240-8. 701 
72. Spafford C, Oakley C, Beard J. Randomized clinical trial comparing 702 
Nordic pole walking and a standard home exercise programme in patients with 703 
intermittent claudication. Journal of British Surgery. 2014;101(7):760-7. 704 
73. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink 705 
MM. Intermittent claudication: clinical effectiveness of endovascular 706 
revascularization versus supervised hospital-based exercise training—707 
randomized controlled trial. Radiology. 2009;250(2):586-95. 708 
74. Stewart AH, Smith FC, Baird RN, Lamont PM. Local versus systemic 709 
mechanisms underlying supervised exercise training for intermittent 710 
claudication. Vascular and endovascular surgery. 2008;42(4):314-20. 711 
34 
 
75. Szymczak M, Oszkinis G, Majchrzycki M. The impact of walking 712 
exercises and resistance training upon the walking distance in patients with 713 
chronic lower limb ischaemia. BioMed research international. 2016;2016. 714 
76. Tebbutt N, Robinson L, Todhunter J, Jonker L. A plantar flexion device 715 
exercise programme for patients with peripheral arterial disease: a randomised 716 
prospective feasibility study. Physiotherapy. 2011;97(3):244-9. 717 
77. Tew G, Nawaz S, Zwierska I, Saxton JM. Limb-specific and cross-718 
transfer effects of arm-crank exercise training in patients with symptomatic 719 
peripheral arterial disease. Clinical Science. 2009;117(12):405-13. 720 
78. Tisi P, Hulse M, Chulakadabba A, Gosling P, Shearman C. Exercise 721 
training for intermittent claudication: does it adversely affect biochemical 722 
markers of the exercise-induced inflammatory response? European Journal of 723 
Vascular and Endovascular Surgery. 1997;14(5):344-50. 724 
79. Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry 725 
versus treadmill exercise training to improve walking distance in patients with 726 
claudication. Vascular Medicine. 2009;14(3):203-13. 727 
80. Tsai JC, Chan P, Wang C-H, Jeng C, Hsieh M, Kao P, et al. The effects 728 
of exercise training on walking function and perception of health status in elderly 729 
patients with peripheral arterial occlusive disease. Journal of internal medicine. 730 
2002;252(5):448-55. 731 
81. Van Schaardenburgh M, Wohlwend M, Rognmo Ø, Mattsson E. Calf 732 
raise exercise increases walking performance in patients with intermittent 733 
claudication. Journal of vascular surgery. 2017;65(5):1473-82. 734 
82. Villemur B, Thoreau V, Guinot M, Gailledrat E, Evra V, Vermorel C, et al. 735 
Short interval or continuous training programs to improve walking distance for 736 
intermittent claudication: Pilot study. Annals of physical and rehabilitation 737 
medicine. 2020;63(6):466-73. 738 
83. Wang J, Zhou S, Bronks R, Graham J, Myers S. Supervised exercise 739 
training combined with ginkgo biloba treatment for patients with peripheral 740 
arterial disease. Clinical rehabilitation. 2007;21(7):579-86. 741 
84. Wang J, Zhou S, Bronks R, Graham J, Myers S. Supervised and home-742 
based exercise training for patients with intermittent claudication. The 743 
International journal of angiology: official publication of the International College 744 
of Angiology, Inc. 2008;17(3):137. 745 
35 
 
85. Woessner M, VanBruggen MD, Pieper CF, Sloane R, Kraus WE, Gow 746 
AJ, et al. Beet the Best? Dietary inorganic nitrate to augment exercise training 747 
in lower extremity peripheral artery disease with intermittent claudication. 748 
Circulation research. 2018;123(6):654-9. 749 
86. Zwierska I, Walker RD, Choksy SA, Male JS, Pockley AG, Saxton JM. 750 
Upper-vs lower-limb aerobic exercise rehabilitation in patients with symptomatic 751 
peripheral arterial disease: a randomized controlled trial. Journal of vascular 752 
surgery. 2005;42(6):1122-30. 753 
87. Wood RE, Sanderson BE, Askew CD, Walker PJ, Green S, Stewart IB. 754 
Effect of training on the response of plasma vascular endothelial growth factor 755 
to exercise in patients with peripheral arterial disease. Clinical science. 756 
2006;111(6):401-9. 757 
88. Tew GA, Humphreys L, Crank H, Hewitt C, Nawaz S, Al-Jundi W, et al. 758 
The development and pilot randomised controlled trial of a group education 759 
programme for promoting walking in people with intermittent claudication. 760 
Vascular medicine. 2015;20(4):348-57. 761 
89. Popplewell M, Bradbury A. Why do health systems not fund supervised 762 
exercise programmes for intermittent claudication? European journal of vascular 763 
and endovascular surgery. 2014;48(6):608-10. 764 
90. Abaraogu U, Ezenwankwo E, Dall P, Tew G, Stuart W, Brittenden J, et 765 
al. Barriers and enablers to walking in individuals with intermittent claudication: 766 
A systematic review to conceptualize a relevant and patient-centered program. 767 
PLoS One. 2018;13(7):e0201095. 768 
91. Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French 769 
DP. A refined taxonomy of behaviour change techniques to help people change 770 
their physical activity and healthy eating behaviours: the CALO-RE taxonomy. 771 
Psychology & health. 2011;26(11):1479-98. 772 
92. Tew GA, Brabyn S, Cook L, Peckham E. The completeness of 773 
intervention descriptions in randomised trials of supervised exercise training in 774 
peripheral arterial disease. PLoS One. 2016;11(3):e0150869. 775 
93. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. 776 
Enhancing treatment fidelity in health behavior change studies: best practices 777 
and recommendations from the NIH Behavior Change Consortium. Health 778 
Psychology. 2004;23(5):443. 779 
36 
 
94. Horner S, Rew L, Torres R. Enhancing intervention fidelity: a means of 780 
strengthening study impact. Journal for Specialists in Pediatric Nursing. 781 
2006;11(2):80-9. 782 
95. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: 783 
updated guidelines for reporting parallel group randomised trials. Trials. 784 
2010;11(1):32. 785 
96. Hacke C, Nunan D, Weisser B. Do exercise trials for hypertension 786 
adequately report interventions? A reporting quality study. International journal 787 
of sports medicine. 2018;39(12). 788 
97. Campbell KL, Neil SE, Winters-Stone KM. Review of exercise studies in 789 
breast cancer survivors: attention to principles of exercise training. British 790 
journal of sports medicine. 2012;46(13):909-16. 791 
98. Abell B, Glasziou P, Hoffmann T. Reporting and replicating trials of 792 
exercise-based cardiac rehabilitation: do we know what the researchers actually 793 
did? Circulation: Cardiovascular Quality and Outcomes. 2015;8(2):187-94. 794 
99. American College of Sports Medicine. ACSM's guidelines for exercise 795 
testing and prescription. Lippincott Williams & Wilkins; 2013. 796 
100. Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, 797 
et al. Society for Vascular Surgery practice guidelines for atherosclerotic 798 
occlusive disease of the lower extremities: management of asymptomatic 799 
disease and claudication. Journal of vascular surgery. 2015;61(3):2S-41S. e1. 800 
101. American College of Sports Medicine. ACSM's Clinical Exercise 801 
Physiology. Lippincott Williams & Wilkins; 2019. 802 
102. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the 803 
CONSORT Statement impact the completeness of reporting of randomised 804 
controlled trials published in medical journals? A Cochrane review a. Systematic 805 
reviews. 2012;1(1):60. 806 
 807 
